By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SciClone Pharmaceuticals, Inc. 

901 Mariner's Island Boulevard
Suite 205
San Mateo  California  94404  U.S.A.
Phone: 650-358-3456 Fax: 650-358-3469



Sigma-Tau Pharmaceuticals  European Union partner for the development and commercialization of ZADAXIN in Europe.

Company News
SciClone (SCLN) Confirms Receipt Of Unsolicited Proposal From GL Capital And ABG Management 11/15/2016 7:25:03 AM
SciClone (SCLN) Reports Third Quarter 2016 Financial Results 11/10/2016 5:02:49 PM
SciClone (SCLN) To Report Third Quarter 2016 Financial Results On November 9, 2016 10/25/2016 9:29:29 AM
SciClone (SCLN) Announces Progress In Advancing Clinical Pipeline For China Pharmaceuticals Market 9/26/2016 9:19:40 AM
Soligenix (SNGX) And SciClone (SCLN) Establish Regional Licensing Agreement For SGX942, A Novel Product Candidate For Oral Mucositis 9/12/2016 6:23:01 AM
SciClone (SCLN) To Present At Two Investor Conferences In September 2016 9/2/2016 7:01:48 AM
SciClone (SCLN) Reports Second Quarter 2016 Financial Results 8/10/2016 10:01:03 AM
SciClone (SCLN) To Report Second Quarter 2016 Financial Results On August 9, 2016 7/28/2016 9:12:14 AM
Bay Area's SciClone (SCLN) Abandons Sale Strategy 7/19/2016 5:56:53 AM
Ability Pharmaceuticals Enters Into A Licensing Agreement With SciClone Pharmaceuticals, Inc. (SCLN) For The Novel Anticancer Agent ABTL0812 For The China Market 5/11/2016 10:19:06 AM